Cases 1 - 8 of 8
DAVIS v. AUROBINDO PHARMA LTD. et al
as 1:2021cv12166
Defendant:
CAMBER PHARMACEUTICALS, INC., HETERO LABS, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO. LTD. and others
Plaintiff:
JEFFREY L. DAVIS
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2020cv13103
Plaintiff:
JANSSEN RESEARCH & DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN INSTITUTIONAL LLC, MYLAN LABORATORIES LIMITED and MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
SVEBEK v. MYLAN LABORATORIES, LTD. et al
as 1:2019cv20609
Defendant:
TORRENT PHARMA, INC, PRINSTON PHARMACEUTICAL INC., MYLAN LABORATORIES, LTD. and others
Plaintiff:
MICHAEL SVEBEK
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al
as 2:2017cv06714
Plaintiff:
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. , SALIX PHARMACEUTICALS, INC. , PROGENICS PHARMACEUTICALS, INC. and others
Defendant:
MYLAN PHARAMACEUTICALS, INC., MYLAN LABORATORIES LTD. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 271
FERRING B.V. v. MYLAN, INC. et al
as 2:2013cv05909
Plaintiff:
FERRING B.V.
Defendant:
MYLAN, INC., MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL
Cause Of Action: 15 U.S.C. § 1126
APTALIS PHARMA US INC. et al v. MYLAN PHARAMACEUTICALS, INC. et al
as 3:2013cv04158
Plaintiff:
APTALIS PHARMA US INC. and APTALIS PHARMA CANADA INC.
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INC.
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
CELGENE CORPORATION et al v. MYLAN PHARAMACEUTICALS, INC.
as 2:2012cv07590
Plaintiff:
CELGENE CORPORATION , NOVARTIS PHARMACEUTICALS CORPORATION and NOVARTIS PHARMA AG
Defendant:
MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
